Literature DB >> 9704645

Up-regulation of alphaEbeta7, a novel integrin adhesion molecule, on T cells from systemic lupus erythematosus patients with specific epithelial involvement.

M Pang1, T Abe, T Fujihara, S Mori, K Tsuzaka, K Amano, J Koide, T Takeuchi.   

Abstract

OBJECTIVE: To determine the possible role of a novel integrin, alphaEbeta7, in the pathogenesis of systemic lupus erythematosus (SLE).
METHODS: Expression of alphaEbeta7 was examined on peripheral blood lymphocytes (PBL) from normal subjects (n = 25) and patients with SLE (n = 31), primary Sjogren's syndrome (n = 7), or polymyositis/dermatomyositis (n = 8) by cytofluorometry and/or immunoprecipitation. Adhesion of alphaEbeta7+ T cells to HSG epithelial cells was investigated using a confocal image analyzer.
RESULTS: After phytohemagglutinin stimulation, expression of alphaEbeta7 on PBL, especially on CD8+ T cells, was significantly higher in SLE patients than in normal subjects (P<0.01). Elevated alphaEbeta7 expression was associated with the presence of oral ulcers or serositis (P<0.05). Activated SLE T cells with enhanced alphaEbeta7 expression strongly adhered to HSG; this adhesion was partially blocked by anti-alphaEbeta7.
CONCLUSION: Expression and adhesion of alphaEbeta7 on activated PBL was significantly increased in patients with SLE with epithelial involvement. This suggests a role of this novel integrin in tissue-specific retention of activated PBL, due to increased alphaEbeta7-E-cadherin interaction, which may contribute to epithelial inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704645     DOI: 10.1002/1529-0131(199808)41:8<1456::AID-ART16>3.0.CO;2-0

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

Review 1.  Alpha E beta 7.

Authors:  P J Kilshaw
Journal:  Mol Pathol       Date:  1999-08

Review 2.  Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.

Authors:  Saskia Thomas; Daniel C Baumgart
Journal:  Inflammopharmacology       Date:  2011-12-20       Impact factor: 4.473

3.  A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes.

Authors:  E G Stefanich; D M Danilenko; H Wang; S O'Byrne; R Erickson; T Gelzleichter; H Hiraragi; H Chiu; S Ivelja; S Jeet; S Gadkari; O Hwang; F Fuh; C Looney; K Howell; V Albert; M Balazs; C Refino; S Fong; S Iyer; M Williams
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

4.  Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.

Authors:  Vaishali R Moulton; George C Tsokos
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

Review 5.  TCRzeta mRNA splice variant forms observed in the peripheral blood T cells from systemic lupus erythematosus patients.

Authors:  Kensei Tsuzaka; Kyoko Nozaki; Chika Kumazawa; Kiyono Shiraishi; Yumiko Setoyama; Keiko Yoshimoto; Tohru Abe; Tsutomus Takeuchi
Journal:  Springer Semin Immunopathol       Date:  2006-09-05

6.  Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients.

Authors:  M Pang; Y Setoyama; K Tsuzaka; K Yoshimoto; K Amano; T Abe; T Takeuchi
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

7.  A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis.

Authors:  Paul J Rutgeerts; Richard N Fedorak; Daan W Hommes; Andreas Sturm; Daniel C Baumgart; Brian Bressler; Stefan Schreiber; John C Mansfield; Marna Williams; Meina Tang; Jennifer Visich; Xiaohui Wei; Mary Keir; Diana Luca; Dimitri Danilenko; Jackson Egen; Sharon O'Byrne
Journal:  Gut       Date:  2012-06-20       Impact factor: 23.059

8.  Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia.

Authors:  Xianfeng Zha; Xiaojuan Yan; Qi Shen; Yuping Zhang; Xiuli Wu; Shaohua Chen; Bo Li; Lijian Yang; Suxia Geng; Jianyu Weng; Xin Du; Yangqiu Li
Journal:  J Hematol Oncol       Date:  2012-12-10       Impact factor: 17.388

Review 9.  Cadherin Signaling in Cancer and Autoimmune Diseases.

Authors:  Margherita Sisto; Domenico Ribatti; Sabrina Lisi
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.